Skip to main content

. 2022 May 9;41(21):3037. doi: 10.1038/s41388-022-02342-6

Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma

Patience Odeniyide ¹, Marielle E Yohe ², Kai Pollard ¹, Angelina V Vaseva ³, Ana Calizo ¹, Lindy Zhang ¹, Fausto J Rodriguez ^4,⁵, John M Gross ⁵, Amy N Allen ¹, Xiaolin Wan ², Romel Somwar ⁶, Karisa C Schreck ^7,⁸, Linda Kessler ⁹, Jiawan Wang ¹, Christine A Pratilas ^1,^7,^✉

PMCID: PMC9122821 PMID: 35534540

Correction to: Oncogene 10.1038/s41388-022-02305-x, published online 22 April 2022

Following the publication of this article a number of copy editing omissions were noted.

These have now been corrected.

Footnotes

The original article can be found online at 10.1038/s41388-022-02305-x.

ACTIONS

RESOURCES